Close Menu

NEW YORK (GenomeWeb) – Enpicom and Cytura Therapeutics have partnered to develop a diagnostic assay for early cancer detection, the Netherlands-based companies announced on Wednesday.

Enpicom develops biomedical software including its recently launched ImmunoGenomiX platform for immune sequencing data analysis, while Cytura is developing cancer drugs targeting genomic instability.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.